Respiratory Medicine
Volume 106, Issue 4 , Pages 515-521 , April 2012

Cause-specific mortality adjudication in the UPLIFT® COPD trial: Findings and recommendations

  • Lorcan P. McGarvey

      Affiliations

    • Centre for Infection and Immunity, Queen's University Belfast, Belfast BT9 7BL, Northern Ireland, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 28 90263 178; fax: +44 28 90329 899.
    • ,
  • Sheldon Magder

      Affiliations

    • McGill University Health Center, Montreal, Quebec H3A 1A1, Canada
    • ,
  • Deborah Burkhart

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877, USA
    • ,
  • Steven Kesten

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877, USA
    • ,
  • Dacheng Liu

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877, USA
    • ,
  • Raymond C. Manuel

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877, USA
    • ,
  • Denis E. Niewoehner

      Affiliations

    • Veterans Affairs Medical Center, Minneapolis, MN 55417, USA

Received 14 September 2011 ,Accepted 19 October 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(11)00350-7

doi: 10.1016/j.rmed.2011.10.009

Respiratory Medicine
Volume 106, Issue 4 , Pages 515-521 , April 2012

Article Tools

* Image Usage & Resolution